NYSE:RMD
Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 3 opinions in the last 12 months.
ResMed Inc. (RMD-N) is positioned well within the digital medical device market, especially focusing on sleep and respiratory monitoring and treatment. Despite initial skepticism about their GLP-1 business, experts now see the company thriving, supported by a solid and consistent business model that targets a growing demographic suffering from sleep apnea. With a dominant market share of 90%, ResMed benefits from increasing demand for sleep-related health solutions. Additionally, strong financial metrics such as a 25% return on equity, growing cash reserves, and proactive debt reduction strategies bolster its attractiveness. The company is recommended with a price target suggesting significant upside potential, making it a solid investment prospect for the coming period.
RMD has been showing positive momentum recently, it is nearing in on its all-time highs, and forward margin expansion is expected to be quite positive. Analyst estimates are trending higher, its margins have been growing, and it generats strong free cash flow, which is partly used for dividends, buybacks, and growing the balance sheet. It is trading at a reasonable valuation of 25X forward earnings, and it has structural tailwinds. We would be comfortable buying the name here today for a long-term hold.
Unlock Premium - Try 5i Free
ResMed Inc. is a American stock, trading under the symbol RMD-N on the New York Stock Exchange (RMD). It is usually referred to as NYSE:RMD or RMD-N
In the last year, 7 stock analysts published opinions about RMD-N. 7 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for ResMed Inc..
ResMed Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for ResMed Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
7 stock analysts on Stockchase covered ResMed Inc. In the last year. It is a trending stock that is worth watching.
On 2025-10-07, ResMed Inc. (RMD-N) stock closed at a price of $283.28.
It has an unaddressed market for CPAP machines. It is a dominant player since people are not likely to change to another product. Weight loss drugs can be part of a total package.